Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H 02196
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- HKD 12.32
- Day Range
- HKD 12.06–12.66
- 52-Week Range
- HKD 11.32–23.20
- Bid/Ask
- HKD 12.64 / HKD 12.66
- Market Cap
- HKD 33.78 Bil
- Volume/Avg
- 1.5 Mil / 3.3 Mil
Key Statistics
- Price/Earnings (Normalized)
- 14.26
- Price/Sales
- 0.74
- Dividend Yield (Trailing)
- 3.73%
- Dividend Yield (Forward)
- 3.73%
- Total Yield
- 3.73%
Company Profile
Shanghai Fosun Pharmaceutical (Group) Co Ltd is engaged in the development, manufacture, and sale of pharmaceutical products and medical equipment, the import and export of medical equipment, and the provision of related and other consulting services and investment management. Its business segments are Pharmaceutical manufacturing, Healthcare Services, Medical devices, and medical diagnosis. It generates the majority of its revenue from the Pharmaceutical manufacturing segment. The company considers merger and acquisition investment as a potential component of its operational growth for expanding its research, development, manufacturing, and marketing capabilities. Its geographic areas are the Chinese mainland, Regions outside the Chinese mainland, and other countries.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Large Core
- Total Number of Employees
- 40,370
- Website
- https://www.fosunpharma.com
Comparables
Valuation
|
Metric
|
02196
|
600521
|
600568
|
|---|---|---|---|
Price/Earnings (Normalized) | 14.26 | 23.51 | — |
Price/Book Value | 0.65 | 2.98 | 1.19 |
Price/Sales | 0.74 | 2.78 | 4.54 |
Price/Cash Flow | 8.72 | 9.03 | 82.87 |
Price/Earnings
02196
600521
600568
Financial Strength
|
Metric
|
02196
|
600521
|
600568
|
|---|---|---|---|
Quick Ratio | 0.71 | 0.81 | 2.86 |
Current Ratio | 1.01 | 1.33 | 4.48 |
Interest Coverage | 2.83 | 6.22 | — |
Quick Ratio
02196
600521
600568
Profitability
|
Metric
|
02196
|
600521
|
600568
|
|---|---|---|---|
Return on Assets (Normalized) | 1.52% | 5.62% | −5.15% |
Return on Equity (Normalized) | 3.71% | 13.24% | −6.42% |
Return on Invested Capital (Normalized) | 2.92% | 7.70% | −6.49% |
Return on Assets
02196
600521
600568
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Ctpckrjd | Bvbd | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Qkccsbktk | Ssjqd | $69.1 Bil | |
HLN
| Haleon PLC ADR | Wdlxxsbh | Bdqdb | $37.8 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Tvjwxdjs | Dggv | $15.7 Bil | |
VTRS
| Viatris Inc | Jfyggwghf | Nsync | $13.8 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Hztddtr | Wnfr | $12.4 Bil | |
CTLT
| Catalent Inc | Jhfdvjvts | Jscdsj | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Qcvkprpc | Bpgp | $4.5 Bil | |
CURLF
| Curaleaf Holdings Inc | Cpsgdgb | Ffxvl | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Vbhghfzz | Gbxyy | $3.5 Bil |